In my mind, thats a win-win situation, she says.
This particular population has been named at-risk MASH and is defined by a significant liver fibrosis (F2), and elevated NAFLD activity score (NAS4)
Her wait and see what you got philosophy means youll have a clearer picture of exactly what skin needs to be addressed and what might have tightened on its own
Let these stories inspire you
However, as with everything, please follow up with your personal care team to ensure these medications are safe and appropriate for you and your specific circumstances
Tirzepatide, a dual agonist of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, has demonstrated superior glycemic control and greater weight reduction compared with GLP-1 receptor agonists alone in patients with type 2 diabetes